(Q46092121)

19 December 2017

title

Elevation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in patients presenting with acute myocardial infarction (English)

1 reference

19 December 2017

8

Martin Borggrefe

1 reference

19 December 2017

Martina Brueckmann

3

object named as

Martina Brueckmann

1 reference

19 December 2017

Siegfried Lang

4

object named as

Siegfried Lang

1 reference

19 December 2017

Thorsten Kälsch

5

object named as

Thorsten Kälsch

1 reference

19 December 2017

author name string

Stefan Kralev

1

1 reference

19 December 2017

Elke Zimmerer

2

1 reference

19 December 2017

Anja Rippert

6

1 reference

19 December 2017

Jihong Lin

7

1 reference

19 December 2017

Hans-Peter Hammes

9

1 reference

19 December 2017

Tim Süselbeck

10

1 reference

19 December 2017

publication date

1 January 2009

1 reference

19 December 2017

Clinical Chemistry and Laboratory Medicine

published in

1 reference

19 December 2017

volume

47

1 reference

19 December 2017

issue

4

1 reference

19 December 2017

page(s)

446-451

1 reference

19 December 2017

Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Differential accumulation of advanced glycation end products in the course of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Advanced glycoxidation. A new risk factor for cardiovascular disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

The role of advanced glycation end products in the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

N(epsilon)-Carboxymethyllysine in diabetic and non-diabetic polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Induction and regulation of hepatocyte apoptosis by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kappaB transcriptional activation and cytokine secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Inflammatory pathways in atherosclerosis and acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Widespread coronary inflammation in unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Serum neopterin and complex stenosis morphology in patients with unstable angina.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

Prognostic significance of blood markers of inflammation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty and effects of pexelizumab, a C5 inhibitor: a substudy of the COMMA trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2009.100

21 January 2018

Identifiers

DOI

10.1515/CCLM.2009.100

1 reference

19 December 2017

PubMed ID

19278364

1 reference

19 December 2017